PrimeIRB is an independent, AAHRPP-accredited Institutional Review Board constituted in 2017 as a wholly-owned subsidiary of Emmes, a global CRO.
PrimeIRB’s foundation is a research culture that prioritizes a commitment to the integrity of the science, and efficient, ethical research conduct. This has established a reputation for performance and has allowed PrimeIRB to develop relationships with global experts in almost any therapeutic field.
We pride ourselves on the ability to provide exemplary service with a single, consistent point of contact, on-call boards, and competitive turnaround times.
The caliber of our staff is unmatched with over 50 years of collective IRB experience and our Board Leadership has unparalleled background in protecting human subjects.